Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ajem.2020.04.048 http://scihub22266oqcxt.onion/10.1016/j.ajem.2020.04.048 32317203!7165109!32317203     free     free     free       Am+J+Emerg+Med 2020 ; 38 (7): 1504-1507 Nephropedia Template TP {{tp|p=32317203|t=2020. Cardiovascular complications in COVID-19 |pdf=|usr=}}{{32317203}} gab.com Text Cardiovascular complications in COVID-19 JO: Am J Emerg Med http://www.kidney.de/pget.php?&tw=1&pmid=32317203 #FOAvip BACKGROUND: The coronavirus disease of 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While systemic inflammation and pulmonary complications can result in significant morbidity and mortality, cardiovascular complications may also occur. OBJECTIVE: This brief report evaluates cardiovascular complications in the setting of COVID-19 infection. DISCUSSION: The current COVID-19 pandemic has resulted in over one million infected worldwide and thousands of death. The virus binds and enters through angiotensin-converting enzyme 2 (ACE2). COVID-19 can result in systemic inflammation, multiorgan dysfunction, and critical illness. The cardiovascular system is also affected, with complications including myocardial injury, myocarditis, acute myocardial infarction, heart failure, dysrhythmias, and venous thromboembolic events. Current therapies for COVID-19 may interact with cardiovascular medications. CONCLUSIONS: Emergency clinicians should be aware of these cardiovascular complications when evaluating and managing the patient with COVID-19. Twit Text FOAVip Cardiovascular complications in COVID-19 ????Am J Emerg Med http://www.kidney.de/pget.php?&tw=1&pmid=32317203 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32317203 #FOAvip English Wikipedia <ref>{{Cite pmid|32317203}}</ref> Cardiovascular complications in COVID-19 #MMPMID32317203 Long B; Brady WJ; Koyfman A; Gottlieb M Am J Emerg Med 2020[Jul]; 38 (7): 1504-1507 PMID32317203show ga BACKGROUND: The coronavirus disease of 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While systemic inflammation and pulmonary complications can result in significant morbidity and mortality, cardiovascular complications may also occur. OBJECTIVE: This brief report evaluates cardiovascular complications in the setting of COVID-19 infection. DISCUSSION: The current COVID-19 pandemic has resulted in over one million infected worldwide and thousands of death. The virus binds and enters through angiotensin-converting enzyme 2 (ACE2). COVID-19 can result in systemic inflammation, multiorgan dysfunction, and critical illness. The cardiovascular system is also affected, with complications including myocardial injury, myocarditis, acute myocardial infarction, heart failure, dysrhythmias, and venous thromboembolic events. Current therapies for COVID-19 may interact with cardiovascular medications. CONCLUSIONS: Emergency clinicians should be aware of these cardiovascular complications when evaluating and managing the patient with COVID-19. |Arrhythmias, Cardiac/pathology/virology[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Cardiovascular Diseases/*pathology/virology[MESH] |Coronavirus Infections/immunology[MESH] |Heart Failure/pathology/virology[MESH] |Humans[MESH] |Myocarditis/pathology/virology[MESH] |Pandemics[MESH] |Pneumonia, Viral/immunology[MESH]Cardiovascular complications in COVID-19 (epmc).pdf DeepDyve Pubget Overpricing